Literature DB >> 36261927

Prepontine cisternal routine for intrathecal targeted drug delivery in craniofacial cancer pain treatment: technical note.

Haocheng Zhou1,2,3, Dong Huang2,3, Dingquan Zou1, Junjiao Hu4, Xinning Li1, Yaping Wang1.   

Abstract

Intrathecal targeted drug delivery provides effective relief for cancer-related pain. However, its validation in management of craniofacial pain remains much less widely practiced, mainly due to the localized diffusion of analgesic agent with current approach. Here, we report our experience of prepontine cisternal routine for placement and implantation of intrathecal targeted drug delivery in two cases of cancer-related craniofacial pain. Lumbar cannulation was applied and the intrathecal catheter tip was positioned at the prepontine cistern under fluoroscopic guidance during the surgical implantation. Postoperative imaging confirmed that the catheter tip was successfully placed in the prepontine cisternal space. Satisfactory control of pain was achieved after intrathecal therapy, with significant reduction of background and breakthrough cancer pain. None obvious complications were observed in this study. Thus, our novel intrathecal routine may provide an alternative option for craniofacial pain caused by tumor, who were insufficiently treated by oral analgesic agents.

Entities:  

Keywords:  Prepontine cisternal; cancer pain; craniofacial; intrathecal; technical note

Mesh:

Substances:

Year:  2022        PMID: 36261927      PMCID: PMC9586698          DOI: 10.1080/10717544.2022.2134507

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.819


  17 in total

1.  Anatomic pathways related to pain in face and neck.

Authors:  J A TAREN; E A KAHN
Journal:  J Neurosurg       Date:  1962-02       Impact factor: 5.115

2.  Cervical intrathecal analgesia for head and neck/upper limb cancer pain: six case reports.

Authors:  Lisa Baker; Jennifer Balls; Claud Regnard; Angus Pridie
Journal:  Palliat Med       Date:  2007-09       Impact factor: 4.762

3.  Efficacy of Short-Term Spinal Cord Stimulation in Acute/Subacute Zoster-Related Pain: A Retrospective Study.

Authors:  Dao-Song Dong; Xue Yu; Cheng-Fu Wan; Yan Liu; Lin Zhao; Qi Xi; Wen-Yao Cui; Qiu-Shi Wang; Tao Song
Journal:  Pain Physician       Date:  2017-07       Impact factor: 4.965

4.  Continuous intracisternal and high cervical intrathecal bupivacaine analgesia in refractory head and neck pain.

Authors:  L Appelgren; M Janson; P Nitescu; I Curelaru
Journal:  Anesthesiology       Date:  1996-02       Impact factor: 7.892

5.  Successful Management of Corneal Neuropathic Pain with Intrathecal Targeted Drug Delivery.

Authors:  Salim M Hayek; Jennifer A Sweet; Jonathan P Miller; Rony R Sayegh
Journal:  Pain Med       Date:  2015-12-14       Impact factor: 3.750

6.  Programmable pump for the administration of morphine in the cisterna magna. A new approach.

Authors:  Manuel Juliá Narváez; José Manuel Galicia Bulnes; José Manuel Montero Elena; Javier Márquez Rivas; Bernarda Márquez Márquez
Journal:  Neuromodulation       Date:  2002-07

7.  Prepontine Cistern Intrathecal Targeted Drug Delivery for Cancer-Related Craniofacial Pain.

Authors:  Dingquan Zou; Wei Zhang; Yaping Wang
Journal:  Pain Med       Date:  2021-12-11       Impact factor: 3.750

8.  High Cervical Intrathecal Targeted Drug Delivery: A Case Report of Refractory Oropharyngeal Cancer Pain.

Authors:  Rajat N Moman; Julie M Rogers; Thomas P Pittelkow
Journal:  Case Rep Oncol Med       Date:  2019-09-10

9.  Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study.

Authors:  David M Schultz; Vwaire Orhurhu; Faizan Khan; Jonathan M Hagedorn; Alaa Abd-Elsayed
Journal:  Neuromodulation       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.